SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549

                               FORM 10-Q/A

        AMENDMENT 1 TO QUARTERLY REPORT UNDER SECTION 13 or 15(d) OF
                    THE SECURITIES EXCHANGE ACT OF 1934

                    For the quarter ended June 30, 1995

                       Commission File Number 1-6926

                             C. R. BARD, INC.

          (Exact name of registrant as specified in its charter)

                                New Jersey
                         (State of incorporation)

                                22-1454160
                   (I.R.S. Employer Identification No.)

             730 Central Avenue, Murray Hill, New Jersey 07974
                 (Address of principal executive offices)

               Registrant's telephone number,
                 including area code:             (908) 277-8000

<PAGE>

                     C. R. BARD, INC. AND SUBSIDIARIES


PART II - OTHER INFORMATION

Item 6.  Exhibits and Reports on Form 8-K

    (a)  Exhibit 27 - Financial Data Schedule

    (b)  Registrant filed a Current Report on Form 8-K dated
         May 31, 1995 with respect to announcing a merger
         agreement between C. R. Bard, Inc. and MedChem Products,
         Inc.    

                                SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                             C. R. BARD, INC.
                             
                               (Registrant)




                             William C. Bopp /s/            
                             William C. Bopp
                             Senior Vice President and
                             Chief Financial Officer




                             
                             Charles P. Grom /s/          
                             Vice President and Controller 
                             and Chief Accounting Officer

September 21, 1995


<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               JUN-30-1995
<CASH>                                          39,400
<SECURITIES>                                         0
<RECEIVABLES>                                  207,000
<ALLOWANCES>                                         0
<INVENTORY>                                    213,300
<CURRENT-ASSETS>                               474,900
<PP&E>                                         325,600
<DEPRECIATION>                                 127,300
<TOTAL-ASSETS>                               1,017,700
<CURRENT-LIABILITIES>                          272,700
<BONDS>                                        199,200
<COMMON>                                        13,000
                                0
                                          0
<OTHER-SE>                                     479,400
<TOTAL-LIABILITY-AND-EQUITY>                 1,017,700
<SALES>                                        541,300
<TOTAL-REVENUES>                               541,300
<CGS>                                          265,200
<TOTAL-COSTS>                                  198,600
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              11,700
<INCOME-PRETAX>                                 69,000
<INCOME-TAX>                                    20,700
<INCOME-CONTINUING>                             48,300
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    48,300
<EPS-PRIMARY>                                      .93
<EPS-DILUTED>                                      .93
        

</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission